Responses by private Mombasa county pharamceutical distributors to challenges faced in implementation of the Kenya national drug policy
View/ Open
Date
2012-10Author
Kassamali, Ateqa S
Type
ThesisLanguage
enMetadata
Show full item recordAbstract
The pharmaceutical industry is an industry protected by patents, it is a highly regulated
and heavy investment industry that is competitive, prominent and growing. As such, it is
prone to malpractices because of loopholes in its supply chain. Registered pharmaceutical
distributors are constantly bombarded by such threats in trying to religiously implement
the guidelines portrayed by the Kenya National Drug Policy.
The objectives of this research are to identify the challenges faced by registered
pharmaceutical distributors within Mombasa county, and to establish how they have
responded to these challenges.
The study population comprises of the 15 pharmaceutical distributors registered by The
Pharmacy and Poisons Board as at end of Dec 2011 within the county. The findings of
the study indicate that there are various challenges distributors face from all key players
of the supply chain, and it was observed that challenges faced is linked to age of the
firms.
It was also observed that, of the 12 distributors with branches in other parts of Kenya,
58.3% of respondents do not directly respond to the challenges facing them, and that
those challenges are dealt with at their headquarters in Nairobi, implying that there is a
need for subsidiary distributors to be better equipped to deal with challenges facing them
on the ground.
It is clear from the findings that prompt action has to be taken by policy regulators to
reduce the malpractices in the pharmaceutical industry, so that the Pharmacy and Poisons
Board can support its quest of availing affordable, safe, efficacious and high quality
The pharmaceutical industry is an industry protected by patents, it is a highly regulated
and heavy investment industry that is competitive, prominent and growing. As such, it is
prone to malpractices because of loopholes in its supply chain. Registered pharmaceutical
distributors are constantly bombarded by such threats in trying to religiously implement
the guidelines portrayed by the Kenya National Drug Policy.
The objectives of this research are to identify the challenges faced by registered
pharmaceutical distributors within Mombasa county, and to establish how they have
responded to these challenges.
The study population comprises of the 15 pharmaceutical distributors registered by The
Pharmacy and Poisons Board as at end of Dec 2011 within the county. The findings of
the study indicate that there are various challenges distributors face from all key players
of the supply chain, and it was observed that challenges faced is linked to age of the
firms.
It was also observed that, of the 12 distributors with branches in other parts of Kenya,
58.3% of respondents do not directly respond to the challenges facing them, and that
those challenges are dealt with at their headquarters in Nairobi, implying that there is a
need for subsidiary distributors to be better equipped to deal with challenges facing them
on the ground.
It is clear from the findings that prompt action has to be taken by policy regulators to
reduce the malpractices in the pharmaceutical industry, so that the Pharmacy and Poisons
Board can support its quest of availing affordable, safe, efficacious and high quality
Sponsorhip
University of NairobiPublisher
School of business